- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07651943
AI-Assisted Interpretation of Ultra-Widefield Retinal Images
Prospective Multi-Center Evaluation of AI-Assisted Interpretation of Ultra-Widefield Retinal Images in a Multi-Reader Crossover Study
The goal of this prospective observational study is to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images.
The main questions it aims to answer are:
whether AI assistance improves the diagnostic performance of ophthalmologists in detecting retinal findings on UWF retinal images; whether AI assistance improves sensitivity, specificity, and inter-reader agreement across clinicians with different levels of experience.
Approximately 600 UWF retinal images prospectively collected from multiple ophthalmic centers in China will be included. Images will be independently annotated by expert retinal specialists to establish reference labels for retinal finding categories.
Four ophthalmologists with different levels of clinical experience, including one senior retinal specialist and three junior ophthalmologists, will participate in a crossover multi-reader study.
For each clinician, the dataset will be randomly divided into two equal subsets. During the first reading session, clinicians will evaluate one subset without AI assistance and the other subset with AI assistance. After a washout interval of at least two weeks, the reading conditions will be reversed in a second reading session with independently randomized image order.
Under the AI-assisted condition, clinicians will be provided with category-level AI prediction probabilities for retinal findings. No localization maps, heatmaps, segmentation overlays, or automated diagnostic recommendations will be displayed. Clinicians will retain full autonomy over final decisions.
Reader performance under AI-assisted and unaided conditions will be compared using expert reference annotations as the ground truth.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a prospective multi-center observational reader study designed to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images.
Approximately 600 UWF retinal images will be prospectively collected from multiple ophthalmic centers in China. Images will be acquired using clinically routine UWF retinal imaging systems and will include a broad spectrum of retinal diseases and retinal findings encountered in real-world clinical practice.
All images will undergo independent expert annotation by retinal specialists to establish reference labels for retinal finding categories. These expert annotations will serve as the reference standard for subsequent performance evaluation.
Four ophthalmologists with different levels of clinical experience will participate in the reader study, including:
one senior retinal specialist with approximately five years of retinal clinical experience; three junior ophthalmologists with approximately two years of ophthalmology residency training.
A randomized crossover multi-reader design will be implemented to minimize recall bias and balance reading conditions.
For each clinician, the image dataset will be randomly divided into two equal subsets (subset A and subset B; approximately 300 images each).
During Round 1:
subset A will be interpreted without AI assistance; subset B will be interpreted with AI assistance.
After a washout interval of at least two weeks, the reading conditions will be reversed during Round 2:
subset A will be interpreted with AI assistance; subset B will be interpreted without AI assistance.
Image order will be independently randomized for each session and each clinician.
Under the unaided condition, clinicians will evaluate retinal images using standard clinical interpretation without AI output.
Under the AI-assisted condition, clinicians will receive category-level AI prediction probabilities for retinal finding categories. The AI output will provide probabilistic confidence scores only and will not include lesion localization maps, heatmaps, segmentation overlays, or automated binary recommendations.
Clinicians will remain blinded to the expert reference labels and to the interpretations of other readers. Final diagnostic decisions will be independently determined by each clinician.
The primary analysis will compare diagnostic performance between unaided and AI-assisted conditions, including sensitivity, specificity, area under the receiver operating characteristic curve (AUC), and inter-reader agreement.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, China
- Chongqing Huaxia Eye Hospital
-
-
Fujian
-
Fuzhou, Fujian, China, 361000
- Fuzhou Eye Hospital
-
Xiamen, Fujian, China, 361000
- Xiamen Eye Center of Xiamen University
-
-
Hebei
-
Hengshui, Hebei, China
- Hengshui Tongrui Eye Hospital
-
-
Shandong
-
Heze, Shandong, China
- Heze Huaxia Eye Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participants undergoing ultra-widefield retinal imaging at participating ophthalmic centers;
Exclusion Criteria:
- Poor-quality or ungradable retinal images;
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
AI-Assisted Interpretation
Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.
|
Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.
|
|
Unaided Interpretation
Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.
|
Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity for retinal finding detection
Time Frame: through study completion, an average of 2 months
|
Sensitivity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions using expert annotations as the reference standard.
|
through study completion, an average of 2 months
|
|
Specificity for retinal finding detection
Time Frame: through study completion, an average of 2 months
|
Specificity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions.
|
through study completion, an average of 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Area under the receiver operating characteristic curve (AUC)
Time Frame: through study completion, an average of 2 months
|
The AUC quantifies the overall ability to correctly distinguish the presence versus absence of predefined retinal findings on ultra-widefield retinal images.
AUC values range from 0.5 (no discriminative ability) to 1.0 (perfect discrimination).
Clinician interpretations will be compared with an expert-adjudicated reference standard under AI-assisted and unaided conditions.
|
through study completion, an average of 2 months
|
|
Inter-reader agreement
Time Frame: At study completion (up to 3 months)
|
Agreement among participating clinicians in classifying predefined retinal findings on ultra-widefield retinal images.
Agreement will be quantified using Cohen's kappa coefficient (for pairwise comparisons) or Fleiss' kappa coefficient (for multiple readers).
Kappa values range from 0 (no agreement beyond chance) to 1 (perfect agreement).
|
At study completion (up to 3 months)
|
|
Diagnostic performance improvement among junior ophthalmologists
Time Frame: At study completion (up to 3 months)
|
Improvement in diagnostic performance of junior ophthalmologists when interpreting ultra-widefield retinal images with AI assistance compared with unaided interpretation, measured by changes in sensitivity, specificity, accuracy, and AUC using the expert-adjudicated reference standard.
|
At study completion (up to 3 months)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Xiuju Chen, Xiamen Eye Center of Xiamen University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- XMYKZX-KY-2026-008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Disease
-
LKC Technologies, Inc.Completed
-
University Hospital, Strasbourg, FranceCompletedInherited Retinal DiseaseFrance
-
Stuart Terry Eye AssociatesNot yet recruiting
-
Indiana UniversityCompleted
-
Retinagenix HoldingsWithdrawnRetinal DisorderUnited States
-
Janssen Research & Development, LLCActive, not recruitingInherited Retinal DiseasesUnited States, Germany, United Kingdom, Italy, Japan, Belgium, France, China, Spain, Israel, Canada, Australia, Austria, Switzerland, Brazil, Finland, South Korea, Denmark
-
Center for Eye Research AustraliaTerminated
-
Topcon Medical Systems, Inc.CompletedNormal Eyes | Eyes With Glaucoma | Eyes With Retinal DiseaseUnited States
-
University Hospital Inselspital, BerneCompletedRetinal DiseaseSwitzerland
-
Peking Union Medical College HospitalRecruitingInherited Retinal DiseasesChina
Clinical Trials on AI-Assisted Interpretation
-
Federal University of Minas GeraisUppsala UniversityNot yet recruitingCardiovascular Abnormalities | Electrocardiogram
-
Kaiser PermanenteEnrolling by invitationEchocardiography, Transthoracic | Echocardiographic SoftwareUnited States
-
The Third Affiliated Hospital of Southern Medical...RecruitingDiagnostic Imaging | Artificial Intelligence (AI) | Common Systemic DiseasesChina
-
Jinling Hospital, ChinaNot yet recruitingIntracranial Aneurysm | CT Angiography | Cluster Randomized Trial | AI (Artificial Intelligence)
-
Cardiocentro TicinoRecruitingAcute Coronary Syndrome (ACS) | Myocardial Infarction (MI)Switzerland
-
Norwegian Institute of Public HealthHelse Vest; Norwegian Cancer Society; Helse Midt-Norge; Helse NordRecruiting
-
Taipei Veterans General Hospital, TaiwanFar Eastern Memorial Hospital; Ministry of Health and Welfare, Taiwan; Taipei... and other collaboratorsNot yet recruiting
-
Xiamen Ophthalmology Center Affiliated to Xiamen...Not yet recruitingRetinal Detachment | Retinal Neovascularization | Subretinal Hemorrhage | Vision-Threatening Retinal Lesions | Urgent Referral Retinal Findings | Pre-retinal Hemorrhage
-
University College, LondonLucida Medical LtdNot yet recruiting
-
Yonsei UniversityNot yet recruitingCoronary Artery Disease | Chest Pain | Acute Coronary SyndromeSouth Korea